BDBM63197 2-(1-benzimidazolyl)-N-[[(E)-2-methyl-3-phenylprop-2-enylidene]amino]acetamide::2-(1H-benzimidazol-1-yl)-N'-[(1E,2E)-2-methyl-3-phenylprop-2-enylidene]acetohydrazide::2-(benzimidazol-1-yl)-N-[[(E)-2-methyl-3-phenyl-prop-2-enylidene]amino]acetamide::2-(benzimidazol-1-yl)-N-[[(E)-2-methyl-3-phenyl-prop-2-enylidene]amino]ethanamide::2-(benzimidazol-1-yl)-N-[[(E)-2-methyl-3-phenylprop-2-enylidene]amino]acetamide::MLS000584770::SMR000203733::cid_1552763

SMILES Cc1cccc(-c2nn(CC(=O)Nc3cncc(C(=O)OCCN(C)C)c3)cc2-c2ccnc3ccccc23)n1

InChI Key InChIKey=POAAROIRKSJBID-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63197   

TargetTGF-beta receptor type-1(Human)
Agomab Spain S.L.U.

US Patent
LigandChemical structure of BindingDB Monomer ID 63197BDBM63197(2-(dimethylamino)ethyl 5-(2-(3-(6-methylpyridin-2-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent